Related Experiment Video
Updated: Aug 14, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[New perspectives in the treatment of hypertension]
1Service de Médecine Interne, Hôpital Saint Michel, 33 rue Olivier de Serres, 75015 Paris.
Insights
Fixed low-dose ACE inhibitor/diuretic combination therapy effectively controlled hypertension in patients over 65. This treatment demonstrated sustained blood pressure control and promising long-term patient compliance.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Hypertension management in elderly patients presents unique challenges.
- First-line treatment options for systolodiastolic and isolated systolic hypertension require evaluation for long-term efficacy and adherence.
- The 18th "Journées de l'Hypertension" conference highlighted new research in antihypertensive therapies.
Purpose:
- To evaluate the long-term efficacy and tolerability of fixed very low dose ACE inhibitor/diuretic bitherapy as a first-line treatment for hypertension in patients over 65.
- To assess the sustained blood pressure control rates in patients with systolodiastolic hypertension and isolated systolic hypertension.
- To compare the outcomes of this bitherapy with other first-line antihypertensive treatments.
Summary:
- Two novel studies investigated fixed very low dose ACE inhibitor/diuretic bitherapy in hypertensive patients aged 65 and older.
- 80% of patients achieved and maintained blood pressure control for 15 months, with dosage adjustments allowed if diastolic blood pressure exceeded 90 mmHg.
- Similar positive outcomes were observed in patients with isolated systolic hypertension.
Impact:
- This fixed low-dose bitherapy shows significant promise for improving long-term blood pressure management in the elderly population.
- The findings suggest enhanced patient compliance and sustained therapeutic effects compared to existing first-line antihypertensive strategies.
- This approach may offer a valuable new option for initiating hypertension treatment in older adults.
Abstract:
Very interesting results of several long-term studies concerning the treatment of hypertension were recently presented at the 18th "Journées de l'Hypertension" conference. Two of them are particularly interesting as, to our knowledge, they are the first studies designed to evaluate the use of fixed very low dose ACE inhibitor/diuretic bitherapy as first-line treatment for systolodiastolic hypertension and isolated systolic hypertension, over a long follow-up period. Both studies included hypertensive patients over the age of 65, and the only option left to the investigators was to adapt the dosage in the case of insufficient blood pressure control (suspine DBP > 90 mmHg). In particular, the results in the overall population show that 80% of patients "controlled" at 3 months, subsequently remained controlled throughout the study period (total of 15 months). The results obtained in isolated systolic hypertension were of the same order of magnitude. The results observed with this fixed very low dose ACE inhibitor/diuretic bitherapy appear very promising in terms of compliance with treatment and long-term blood pressure control, compared to those obtained with any other antihypertensive drugs indicated as first-line treatment of hypertension.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

